Skip to Main Content

Paper Details

Daratumumab in Patients With Bortezomib-Refractory Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits.
Kidney Int Rep
7
2021
Bortezomib, Immunoglobulin, Monoclonal Immunoglobulin Deposits, Patients, Proliferative Glomerulonephritis
Author NameAffiliation
Salem AlmaaniThe Ohio State University Wexner Medical Center
Samir M ParikhThe Ohio State University Wexner Medical Center
Samir M ParikhThe Ohio State University Wexner Medical Center
Brad H RovinThe Ohio State University Wexner Medical Center
Brad H RovinThe Ohio State University Wexner Medical Center
Isabelle AyoubThe Ohio State University Wexner Medical Center
  • 1 - 6

Datasets

Release 1.2